Your browser doesn't support javascript.
loading
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection-response to Guangting Zeng and Yuchi Zhou.
Adegunsoye, Ayodeji; Baccile, Rachel; Best, Thomas J; Zaksas, Victoria; Zhang, Hui; Karnik, Rasika; Patel, Bhakti K; Solomonides, Anthony E; Parker, William F; Solway, Julian.
Afiliação
  • Adegunsoye A; Section of Pulmonary & Critical Care, Department of Medicine, The University of Chicago, Chicago, IL, USA.
  • Baccile R; Committee on Clinical Pharmacology & Pharmacogenomics, The University of Chicago, Chicago, IL, USA.
  • Best TJ; Center for Health and the Social Sciences, The University of Chicago, Chicago, IL, USA.
  • Zaksas V; Center for Health and the Social Sciences, The University of Chicago, Chicago, IL, USA.
  • Zhang H; Center for Translational Data Science, The University of Chicago, Chicago, IL, USA.
  • Karnik R; Clever Research Lab, Springfield, IL, USA.
  • Patel BK; Center for Health and the Social Sciences, The University of Chicago, Chicago, IL, USA.
  • Solomonides AE; Section of General Internal Medicine, Department of Medicine, The University of Chicago, Chicago, IL, USA.
  • Parker WF; Section of Pulmonary & Critical Care, Department of Medicine, The University of Chicago, Chicago, IL, USA.
  • Solway J; Outcomes Research Network, Research Institute, NorthShore University HealthSystem, Evanston, IL, USA.
Lancet Reg Health Am ; 26: 100611, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37829195
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article